A Study of Pemetrexed in Children With Recurrent Cancer

Clinical trial NCT00520936 · COMPLETED

Trial details

NCT number: NCT00520936
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Osteosarcoma Medulloblastoma Sarcoma, Ewing's Neuroblastoma (Measurable Disease)Neuroblastoma (Metaiodobenzylguanidine Positive Evaluable)Rhabdomyosarcoma Ependymoma Non-brainstem High-grade Glioma

Start date: 2007-09-01
Primary completion: 2010-02-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.